Yapislar Hande, Taskin Eylem
Department of Physiology, Istanbul Bilim University, Medical Faculty, Istanbul, Turkey.
Department of Physiotherapy and Rehabilitation, Istanbul Bilim University, School of Health Sciences, Istanbul, Turkey.
Med Sci Monit. 2014 Mar 11;20:399-405. doi: 10.12659/MSM.890528.
Chronic kidney disease (CKD) is a major health problem worldwide. Oxidative stress is one of the mediators of this disease. Systemic complications of oxidative stress are involved in the pathogenesis of hypertension, endothelial dysfunction, shortened erythrocyte lifespan, deformability, and nitric oxide (NO) dysfunction. L-carnosine is known as an antioxidant. In this study, our aim was to investigate the effect of carnosine on hemorheologic and cardiovascular parameters in CKD-induced rats.
We used 4-month-old male Sprague-Dawley rats divided into 4 groups of 6 rats each. Three days after subtotal nephrectomy and sham operations, the surviving rats were divided into the 4 groups; 1) Sham (S), 2) Sham+Carnosine (S-C), 3) Subtotal nephrectomy (Nx), and 4) Subtotal nephrectomy + Carnosine (N-C). Carnosine was injected intraperitoneally (i.p.) (50 mg/kg) for 15 days. The control group received the same volume of physiological saline.
In CKD rats, malondialdehyde (MDA) levels were increased, and NO and RBC deformability were decreased compared to Sham. Carnosine treatment decreased MDA levels, improved RBC (red blood cell) ability to deform, and increased NO levels. However, carnosine did not affect blood pressure levels in these rats.
We found that carnosine has beneficial effects on CKD in terms of lipid peroxidation and RBC deformability. Carnosine may have a healing effect in microcirculation level, but may not have any effect on systemic blood pressure in CKD-induced rats.
慢性肾脏病(CKD)是全球范围内的一个主要健康问题。氧化应激是该疾病的介导因素之一。氧化应激的全身并发症参与了高血压、内皮功能障碍、红细胞寿命缩短、变形性以及一氧化氮(NO)功能障碍的发病机制。L-肌肽是一种已知的抗氧化剂。在本研究中,我们的目的是研究肌肽对CKD诱导大鼠的血液流变学和心血管参数的影响。
我们使用4个月大的雄性Sprague-Dawley大鼠,将其分为4组,每组6只。在进行次全肾切除和假手术后三天,将存活的大鼠分为4组:1)假手术组(S),2)假手术+肌肽组(S-C),3)次全肾切除组(Nx),4)次全肾切除+肌肽组(N-C)。肌肽通过腹腔注射(i.p.)(50 mg/kg),持续15天。对照组接受相同体积的生理盐水。
与假手术组相比,CKD大鼠的丙二醛(MDA)水平升高,NO和红细胞变形性降低。肌肽治疗降低了MDA水平,改善了红细胞(RBC)的变形能力,并提高了NO水平。然而, 肌肽对这些大鼠的血压水平没有影响。
我们发现肌肽在脂质过氧化和红细胞变形性方面对CKD有有益作用。肌肽可能在微循环水平上具有治疗作用,但对CKD诱导大鼠的全身血压可能没有任何影响。